SCHEMBL2994430

SCHEMBL2994430

O=[C]Nc1ccc(S(=O)(=O)N2CCCC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.63
ALDH1A1 P00352 8/20 0.61
HSD17B10 Q99714 1/20 0.59
PKM P14618 3/20 0.56
POLB P06746 3/20 0.55
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
MAPT P10636 4/20 0.55
HTT P42858 3/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
ALOX15 P16050 1/20 0.54
RECQL P46063 1/20 0.54
F13A1 P00488 1/20 0.54
TGM2 P21980 1/20 0.54
TGM1 P22735 1/20 0.54
GAA P10253 2/20 0.54
HPGD P15428 1/20 0.54
TDP1 Q9NUW8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14283239 0.79 ALDH1A1 (0.70) USP2ALDH1A1HSD17B10PKMPOLB
SCHEMBL12455096 0.79 USP2 (0.68) USP2ALDH1A1HSD17B10PKMPOLB
SCHEMBL4655481 0.77 USP2 (0.71) USP2ALDH1A1HSD17B10POLBMEN1
SCHEMBL4655484 0.77 USP2 (0.71) USP2ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6945990 0.77 USP2 (0.71) USP2ALDH1A1HSD17B10POLBMEN1
SCHEMBL436674 0.76 PKM (0.89) USP2ALDH1A1HSD17B10PKMPOLB
SCHEMBL13982817 0.75 ALDH1A1 (0.65) USP2ALDH1A1HSD17B10PKMPOLB
SCHEMBL13982806 0.75 USP2 (0.67) USP2ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL31527639 0.75 USP2 (0.67) USP2ALDH1A1HSD17B10POLBMEN1
SCHEMBL27183343 0.75 ALDH1A1 (0.69) USP2ALDH1A1HSD17B10PKMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518960-B2 Antiviral drugs for treatment or prevention of dengue infection SIGA TECHNOLOGIES, INC. (US) 2013-08-27 US disclosed
US-20100189685-A1 Antiviral Drugs for Treatment or Prevention of Dengue Infection SIGA TECHNOLOGIES, INC. 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189685-A1 Antiviral Drugs for Treatment or Prevention of Dengue Infection EIF2AK2, HAVCR2, SNRPE USP2 3743/4885ALDH1A1 2072/4885HSD17B10 3737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.